Evidence map›Paper›PMID 36284820›Full record

ArticleCureus2022

COVID-19 Vaccine Hesitancy Among Patients Attending the General Outpatient Clinic in a Tertiary Hospital in Southern Nigeria.

Samuel O Ilikannu, Omozele M Uwadia, Idotenyin Enyi, Valentine E Idama, Christian C Adugo, Celestina Yusuf, Alexsandra Urhi, Chikodili Ochuba, Omotola Akinade, Gabriel Alugba

Abstract read
In one paragraph

Article in Cureus, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Samuel O IlikannuObstetrics and Gynecology, Federal Medical Center, Asaba, NGA.
Omozele M UwadiaPediatrics and Child Health, Federal Medical Centre, Asaba, NGA.
Idotenyin EnyiCommunity Medicine, Federal Medical Centre, Asaba, NGA.
Valentine E IdamaAcute Medicine Unit, Chesterfield Royal Hospital, Chesterfield, GBR.
Christian C AdugoInternal Medicine, Federal Medical Centre, Asaba, NGA.
Celestina YusufFamily Medicine, Federal Medical Centre, Asaba, NGA.
Alexsandra UrhiPsychiatry, Federal Neuro-Psychiatric Hospital, Benin City, NGA.
Chikodili OchubaHealth, Ethics and Society, Maastricht University, Maastricht, NLD.
Omotola AkinadeInternal Medicine, General Hospital Ikorodu, Ikorodu, NGA.
Gabriel AlugbaInternal Medicine, Delta State University, Abraka, NGA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background As most of the available studies on acceptance of the coronavirus disease 2019 (COVID-19) vaccine were done prior to the development of a vaccine, this study aimed to determine the current willingness to receive the available COVID-19 vaccines in Nigeria and ascertain factors influencing its acceptance. Methodology A cross-sectional descriptive study using a paper-based questionnaire was conducted among patients aged 18 years and above, attending the General Outpatient Clinic of Federal Medical Centre, Asaba, Delta State, Nigeria (n= 366). Data were analyzed using SPSS version 26 (Armonk, NY: IBM Corp.). Univariate and bivariate analyses were conducted at an alpha level of significance set at p<0.05. Results This study comprised 366 participants, of which 56.28% were willing to take a COVID-19 vaccine if it was made available to them. Generally, it was found that participants aged <40 years (56.90%), females (56.88%), singles (57.32%), and unemployed respondents (67.44%) were more willing to receive the vaccine than others. Those who agreed that COVID-19 was not an invention by man (p=0.031; OR=1.64; 95% CI=1.05, 2.58) were more likely to receive a vaccine. Suspicion of the government's intentions about COVID-19 was a perceived barrier by participants to accepting a vaccine. Conclusion Our findings represent one of the few estimates of the acceptability of the COVID-19 vaccine in Nigeria. They can be used to guide the planning and development of future public health efforts, increasing the awareness of the COVID-19 vaccine, its acceptability, and its uptake.

Indexed as

corona viruscovid-19covid-19 vaccinepandemicvaccine hesitancy

Identifiers

PMID36284820
PMCPMC9583703

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.